Eli Lilly posted strong first-quarter earnings as demand for its obesity and diabetes drugs surged | Collector

Quartz

Eli Lilly posted strong first-quarter earnings as demand for its obesity and diabetes drugs surged

Worldwide revenue climbed 56% to $19.8 billion in the first quarter, led by Mounjaro's 125% sales jump